Share

Out of Practice: Why Retirement Doesn’t Always Mean You Stop Seeing Patients

santen When Endocrine Society past-president Richard J. Santen, MD, achieved “emeritus” status at the University of Virginia in Charlottesville, he was far from being done with practicing medicine. That’s when he decided to continue seeing patients throughout southwest Virginia from the comfort of his home and with help from telehealth technology and the Federally Funded Community...
Share

The Importance of Symptom Control: A Holistic Approach to Treating Acromegaly

GEER_CLINIC_0107r Despite successful medical intervention, people with acromegaly don’t always share their clinician’s optimistic outlook. Eliza B. Geer, MD, director of Memorial Sloan Kettering’s Multidisciplinary Pituitary & Skull Base Tumor Center, takes us through a holistic approach to treating this often-confounding condition and how a team-based methodology is frequently the key to success. Recently, I was...
Share

Pro Golfer Azahara Muñoz Shares Her Experience with Hashimoto’s Disease

Aza Photo 2 When professional golfer Azahara Muñoz started developing symptoms of Hashimoto’s thyroiditis – tiredness, cold extremities – she chalked them up to practicing too hard or traveling too much. It’s a stressful job. “You almost always have an excuse for it,” she says. But then around 2016, Muñoz noticed she began suffering from anxiety. Her hair...
Share

From A Distance: The Endocrine Society’s Newest Perspective Statement on Telehealth Encourages Individualized Care

october 2022 cover This month, The Journal of Clinical Endocrinology & Metabolism is publishing “Appropriate Use of Telehealth Visits in Endocrinology: Perspective Statement of the Endocrine Society.” Since this new modality is here to stay, Endocrine News talks to the authors about which patients are better candidates for telehealth than others, why endocrinology seems tailor-made for this new...
Share

Endocrine Society Experts Recommend Individualized Approach to Use of Telehealth  

Policy perspective explores factors to maximize effectiveness of telehealth Following rapid growth during the COVID-19 pandemic, telehealth visits are expected to remain an important part of endocrine care, according to a new Endocrine Society policy perspective published in The Journal of Clinical Endocrinology & Metabolism.   Health care providers need to consider a variety of...
Share

Positive Clinical Data for Oral Treatment of Acromegaly Presented at ENDO

ENDO 2022 saw the presentation of positive clinical data from the open-label extensions (OLEs) of two of the Phase 3 trials of oral octreotide for patients with acromegaly. Amryt is marketing the drug as Mycapssa. Data presented in a late-breaking poster presentation of the 2nd year of the OLE of OPTIMAL (NCT03252353), a randomized, double-blind...
Share

FDA Approves Spinal Cord Stimulation Therapy for Treating Chronic Pain Resulting from Diabetic Peripheral Neuropathy

The U.S. Food and Drug Administration (FDA) last month approved a rechargeable neurostimulator and a recharge-free neurostimulator for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN). Medtronic is marketing the products as Intellis™ and Vanta™, respectively. DPN is a debilitating and progressive neurological disorder that affects approximately 30% of people with diabetes,...
Share

2021 Progress Report: Part 1

december 2021 cover Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. From remarkable new treatments for acromegaly, thyroid eye disease, hypoglycemia, and diabetes to new devices aimed at glucose monitoring in adults and children, a mail-in semen analysis kit, and much more, Endocrine News takes a closer...